Skip to content
OpenCapital
Get started

Briacell Therapeutics Corp. BCTX Q1 2026 earnings

Reported March 10, 2026 · After market close

EPS-$2.58Beat by $2.26
EPS estimate-$4.84

Next report

Date not yet announced

Versus estimates

Diluted EPS

Q2 2026-$0.99
Q1 2026-$2.58Beat by $2.26
Q4 2025-$4.35Q3 2025-$10.49Beat by $1.62Q2 2025-$16.40Beat by $1.20Q1 2025-$23.30Miss by $3.90

Ask the moment Briacell Therapeutics Corp. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Briacell Therapeutics Corp. report Q1 2026 earnings?
Briacell Therapeutics Corp. (BCTX) reported Q1 2026 earnings on March 10, 2026 after market close.
What were Briacell Therapeutics Corp.'s Q1 2026 revenue and EPS?
Briacell Therapeutics Corp. reported eps of $-2.58 for Q1 2026.
Did Briacell Therapeutics Corp. beat estimates in Q1 2026?
EPS beat the consensus estimate of $-4.84 by $2.26.
How did Briacell Therapeutics Corp.'s Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 88.9% from $-23.30.
Where can I find Briacell Therapeutics Corp.'s Q1 2026 SEC filings?
You can read the 8-K earnings release (0001493152-26-009382) and the 10-Q periodic report (0001493152-26-009557) directly on SEC EDGAR. The filing index links above go to sec.gov.